Search Results - "Massias, L"

Refine Results
  1. 1

    Activity of fosfomycin alone or combined with temocillin in vitro and in a murine model of peritonitis due to KPC-3- or OXA-48-producing Escherichia coli by Berleur, M, Guérin, F, Massias, L, Chau, F, Poujade, J, Cattoir, V, Fantin, B, de Lastours, V

    Published in Journal of antimicrobial chemotherapy (01-11-2018)
    “…Alternative therapeutic regimens are urgently needed against carbapenemase-producing Enterobacteriaceae. Fosfomycin often remains active against KPC and OXA-48…”
    Get full text
    Journal Article
  2. 2

    Dimercaptosuccinic acid in combination with carbapenems against isogenic strains of Escherichia coli producing or not producing a metallo-β-lactamase in vitro and in murine peritonitis by Cheminet, G, de Lastours, V, Poirel, L, Chau, F, Peoc'h, K, Massias, L, Fantin, B, Nordmann, P

    Published in Journal of antimicrobial chemotherapy (01-12-2020)
    “…Carbapenemase-producing Enterobacterales represent a major therapeutic challenge. MBLs, requiring zinc at their catalytic site, could be inhibited by…”
    Get full text
    Journal Article
  3. 3

    Pharmacokinetic study of anidulafungin in ICU patients with intra-abdominal candidiasis by Dupont, H, Massias, L, Jung, B, Ammenouche, N, Montravers, P

    Published in Journal of antimicrobial chemotherapy (01-05-2017)
    “…Only limited pharmacokinetic data are available for anidulafungin in ICU patients, especially in patients treated for severe intra-abdominal infection (IAI)…”
    Get full text
    Journal Article
  4. 4

    Ciprofloxacin Treatment Failure in a Murine Model of Pyelonephritis Due to an AAC(6′)-Ib-cr-Producing Escherichia coli Strain Susceptible to Ciprofloxacin In Vitro by GUILLARD, T, CAMBAU, E, CHAU, F, MASSIAS, L, DE CHAMPS, C, FANTIN, B

    Published in Antimicrobial Agents and Chemotherapy (01-12-2013)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  5. 5

    Population pharmacokinetics and dosing simulations of amoxicillin in obese adults receiving co-amoxiclav by Mellon, G, Hammas, K, Burdet, C, Duval, X, Carette, C, El-Helali, N, Massias, L, Mentré, F, Czernichow, S, Crémieux, A-C

    Published in Journal of antimicrobial chemotherapy (01-12-2020)
    “…Pneumonia, skin and soft tissue infections are more frequent in obese patients and are most often treated by co-amoxiclav, using similar dosing regimens to…”
    Get full text
    Journal Article
  6. 6

    Activity of temocillin in a lethal murine model of infection of intra-abdominal origin due to KPC-producing Escherichia coli by Alexandre, K, Chau, F, Guérin, F, Massias, L, Lefort, A, Cattoir, V, Fantin, B

    Published in Journal of antimicrobial chemotherapy (01-07-2016)
    “…Temocillin is a 6-α-methoxy derivative of ticarcillin that shows in vitro activity against Enterobacteriaceae producing Klebsiella pneumoniae carbapenemase…”
    Get full text
    Journal Article
  7. 7

    Activity of temocillin in a murine model of urinary tract infection due to Escherichia coli producing or not producing the ESBL CTX-M-15 by Soubirou, J F, Rossi, B, Couffignal, C, Ruppé, E, Chau, F, Massias, L, Lepeule, R, Mentre, F, Fantin, B

    Published in Journal of antimicrobial chemotherapy (01-05-2015)
    “…Temocillin is a 6α-methoxy derivative of ticarcillin that is resilient to ESBLs. Prospective data about its in vivo activity remain scarce. Our aims were: (i)…”
    Get full text
    Journal Article
  8. 8

    Cefotaxime and Amoxicillin-Clavulanate Synergism against Extended-Spectrum-β-Lactamase-Producing Escherichia coli in a Murine Model of Urinary Tract Infection by Rossi, B, Soubirou, J F, Chau, F, Massias, L, Dion, S, Lepeule, R, Fantin, B, Lefort, A

    Published in Antimicrobial agents and chemotherapy (01-01-2016)
    “…We investigated the efficacies of cefotaxime (CTX) and amoxicillin (AMX)-clavulanate (CLA) (AMC) against extended-spectrum-β-lactamase (ESBL)-producing…”
    Get full text
    Journal Article
  9. 9

    Population pharmacokinetics of single-dose amikacin in critically ill patients with suspected ventilator-associated pneumonia by Burdet, C., Pajot, O., Couffignal, C., Armand-Lefèvre, L., Foucrier, A., Laouénan, C., Wolff, M., Massias, L., Mentré, F.

    Published in European journal of clinical pharmacology (01-01-2015)
    “…Aims Modifications of antimicrobials’ pharmacokinetic parameters have been reported in critically ill patients, resulting in a risk of treatment failure. We…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Comparison of Six Generic Vancomycin Products for Treatment of Methicillin-Resistant Staphylococcus aureus Experimental Endocarditis in Rabbits by TATTEVIN, P, SALEH-MGHIR, A, DAVIDO, B, GHOUT, I, MASSIAS, L, GARCIA DE LA MARIA, C, MIRO, J. M, PERRONNE, C, LAURENT, F, CREMIEUX, A. C

    Published in Antimicrobial Agents and Chemotherapy (01-03-2013)
    “…OA  Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  12. 12

    Impact of imipenem and amikacin pharmacokinetic/pharmacodynamic parameters on microbiological outcome of Gram-negative bacilli ventilator-associated pneumonia by Pajot, O, Burdet, C, Couffignal, C, Massias, L, Armand-Lefevre, L, Foucrier, A, Da Silva, D, Lasocki, S, Laouénan, C, Mentec, H, Mentré, F, Wolff, M

    Published in Journal of antimicrobial chemotherapy (01-05-2015)
    “…Despite recent advances, antibiotic therapy of ventilator-associated pneumonia (VAP) in ICU patients is still challenging. We assessed the impact of imipenem…”
    Get full text
    Journal Article
  13. 13

    Alveolar and serum concentrations of imipenem in two lung transplant recipients supported with extracorporeal membrane oxygenation by Welsch, C., Augustin, P., Allyn, J., Massias, L., Montravers, P., Allou, N.

    Published in Transplant infectious disease (01-02-2015)
    “…Venovenous extracorporeal membrane oxygenation (ECMO) is increasingly used in patients with respiratory failure who fail conventional treatment. Postoperative…”
    Get full text
    Journal Article
  14. 14

    The Emergence of Linezolid Resistance among Enterococci in Intestinal Microbiota of Treated Patients Is Unrelated to Individual Pharmacokinetic Characteristics by BOURGEOIS-NICOLAOS, N, NGUYEN, T. T, ANDREMONT, A, DUVAL, X, DEFRANCE, G, MASSIAS, L, ALAVOINE, L, LEFORT, A, NOEL, V, SENNEVILLE, E, DOUCET-POPULAIRE, F, MENTRE, F

    Published in Antimicrobial agents and chemotherapy (01-05-2014)
    “…Linezolid is an antimicrobial agent for the treatment of multiresistant Gram-positive infections. We assessed the impact of linezolid on the microbiota and the…”
    Get full text
    Journal Article
  15. 15

    Worsening pneumonitis due to a pharmacokinetic drug–drug interaction between everolimus and voriconazole in a renal transplant patient by Lecefel, C., Eloy, P., Chauvin, B., Wyplosz, B., Amilien, V., Massias, L., Taburet, A.‐M., Francois, H., Furlan, V.

    “…Summary What is known and objective Azole antifungals, prescribed prophylactically to avoid severe infections in immunosuppressed organ transplant recipients,…”
    Get full text
    Journal Article
  16. 16

    Controlled release of vancomycin from Poloxamer 407 gels by Veyries, M.L, Couarraze, G, Geiger, S, Agnely, F, Massias, L, Kunzli, B, Faurisson, F, Rouveix, B

    Published in International journal of pharmaceutics (10-12-1999)
    “…The purpose of this study was to investigate Poloxamer 407 25% (w/w) formulations aimed at prolonging the residence time of vancomycin, a time-dependent…”
    Get full text
    Journal Article
  17. 17

    Comparison of lithium concentrations in red blood cells and plasma in samples collected for TDM, acute toxicity, or acute-on-chronic toxicity by CAMUS, M, HENNERE, G, BARON, G, PEYTAVIN, G, MASSIAS, L, MENTRE, F, FARINOTTI, R

    Published in European journal of clinical pharmacology (01-11-2003)
    “…Lithium salts (Li+) are still one of the most appropriate treatments in manic-depressive disorders. Since Li+ has a narrow therapeutic index, plasma levels…”
    Get full text
    Journal Article
  18. 18

    Painful peripheral neuropathy associated with voriconazole during the treatment of chronic cavitary pulmonary aspergillosis by Gendrot, A, de La Blanchardière, A, de La Gastine, B, Fromager, G, Massias, L, Verdon, R

    Published in La revue de medecine interne (01-02-2010)
    “…Chronic cavitary pulmonary aspergillosis requires a first-line prolonged treatment with itraconazole or voriconazole. We report a 71-year-old immunocompetent…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Role of nitric oxide and cyclooxygenase pathways in the coronary vascular effects of halothane, isoflurane and desflurane in red blood cell-perfused isolated rabbit hearts by Beaussier, M., Mouren, S., Souktani, R., Arthaud, M., Massias, L., Vicaut, E., Lienhart, A., Coriat, P.

    Published in British journal of anaesthesia : BJA (01-03-2002)
    “…The coronary vascular endothelium could mediate some of the coronary effects of halogenated anaesthetic agents. The role of the endothelial vasodilator…”
    Get full text
    Journal Article